Overview
Name
Fund Family
Underlying Index
Inception Date
Exchange
Description
The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index. The Underlying Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by NASDAQ, including minimum market capitalization and liquidity requirements. The Fund generally invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Underlying Index.
Investment Information
Managed Assets, $K
Shares Outstanding, K
Asset Class
Sectors
ETFs - Biotech
60-Month Beta
Net Asset Value
Management Fee
Most Recent Dividend
Last Dividend Date
Dividend Yield
Has Options
20-Day Average Volume
52-Week RangeLow price117.28-High price150.57
YTD Return %
1-Year %Chg
3-Year %Chg
5-Year %Chg